Immunopathogenesis of primary sclerosing cholangitis: possible role of a shared colonic and biliary epithelial antigen

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Gastroenterology and Hepatology

• Publication date

  2004-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1440-1746.2004.03690.x
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Isolation and Characterization

  2016cited by this paper
• Relationship of Extraintestinal Involvements in Inflammatory Bowel Disease (New Insights into Autoimmune Pathogenesis)

  2004cited by this paper
• High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6

  2002cited by this paper
• Role of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice.

  2002cited by this paper
• Deficiency of a novel biliary epithelial protein crossreactive to colon epithelium in the bile of patients with primary sclerosing cholangitis (PSC)

  2001cited by this paper
• Cellular immune response against tropomyosin isoform 5 in ulcerative colitis.

  2001cited by this paper
• "Atypical p-ANCA" in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines.

  2000cited by this paper
• Autoantibodies against the specific epitope of human tropomyosin(s) detected by a peptide based enzyme immunoassay in sera of patients with ulcerative colitis show antibody dependent cell mediated cytotoxicity against HLA-DPw9 transfected L cells

  2000cited by this paper
• Externalization of tropomyosin isoform 5 in colon epithelial cells

  1999cited by this paper
• Expression of CD44 on bile ducts in primary sclerosing cholangitis and primary biliary cirrhosis.

  1999cited by this paper
• Low monitor units: significance in special therapy.

  1999cited by this paper
• Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis.

  1999cited by this paper
• Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population.

  1998cited by this paper
• Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colitis.

  1998cited by this paper
• Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features.

  1998cited by this paper
• Enhanced cytokine mRNA expression in Primary Sclerosing Cholangitis (PSC) and autoimmune liver diseases.

  1997cited by this paper
• A revised natural history model for primary sclerosing cholangitis.

  1997cited by this paper
• Preferential Vβ3 usage by hepatic T lymphocytes in patients with primary sclerosing cholangitis

  1997cited by this paper
• Risk of primary sclerosing cholangitis is associated with nonsmoking behavior.

  1996cited by this paper
• Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium.

  1994cited by this paper
• Epidemiology of primary sclerosing cholangitis in Spain

  1994cited by this paper
• A shared and unique peptide in the human colon, eye, and joint detected by a monoclonal antibody.

  1994cited by this paper
• Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver.

  1994cited by this paper
• Autoimmunity to cytoskeletal protein tropomyosin. A clue to the pathogenetic mechanism for ulcerative colitis.

  1993cited by this paper
• Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis.

  1992cited by this paper
• Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis.

  1992cited by this paper
• Amino acid substitutions at position 38 of the DRβ polypeptide confer susceptibility to and protection from primary sclerosing cholangitis

  1992cited by this paper
• Extracolonic diagnoses in ulcerative colitis: an epidemiological study.

  1990cited by this paper
• A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody.

  1990cited by this paper
• The production and characterization of monoclonal antibodies to a human colonic antigen associated with ulcerative colitis: cellular localization of the antigen by using the monoclonal antibody.

  1987cited by this paper
• Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis.

  1985cited by this paper
• Association of primary sclerosing cholangitis with HLA-B8.

  1983cited by this paper
• Sclerosing cholangitis in ulcerative colitis.

  1980cited by this paper
• The Production of

  1979cited by this paper
• Isolation and characterization of colonic tissue-bound antibodies from patients with idiopathic ulcerative colitis.

  1978cited by this paper

• Diagnosis and Management of Autoimmune Hepatitis: A Clinical Guide

  2020cites this paper
• The Pathogenesis of Autoimmune Liver Diseases

  2020cites this paper
• Genetics of primary sclerosing cholangitis and pathophysiological implications

  2017cites this paper
• Primary sclerosing cholangitis - a comprehensive review.

  2017cites this paper
• Genetics in primary sclerosing cholangitis.

  2012cites this paper
• Autoantibodies and liver disease: uses and abuses.

  2010cites this paper
• Autoantibodies in primary sclerosing cholangitis.

  2008cites this paper
• The prevalence of autoantibodies to: myosin, troponin, tropomyosin and myoglobin in patients with circulating triiodothyronine and thyroxine autoantibodies (THAA).

  2007cites this paper